p16^INK4a Peptide mimetics identified via virtual screeningKLEIN, Mark A; MAYO, Kevin H; KRATZKE, Robert A et al.Bioorganic & medicinal chemistry letters (Print). 2010, Vol 20, Num 1, pp 403-405, issn 0960-894X, 3 p.Article

Synthesis of [¹⁸F]anginex with high specific activity [¹⁸F]fluorobenzaldehyde for targeting angiogenic activity in solid tumorsAPANA, Scott M; GRIFFIN, Robert J; KOONCE, Nathan A et al.Journal of labelled compounds & radiopharmaceuticals. 2011, Vol 54, Num 11-12, pp 708-713, issn 0362-4803, 6 p.Article

Gene expression of tumor angiogenesis dissected : specific targeting of colon cancer angiogenic vasculatureVAN BEIJNUM, Judy R; DINGS, Ruud P; VAN DER LINDEN, Edith et al.Blood. 2006, Vol 108, Num 7, pp 2339-2348, issn 0006-4971, 10 p.Article

Structure/function studies of an endotoxin-neutralizing peptide derived from bactericidal/permeability-increasing proteinWASILUK, Karen R; LESLIE, Daniel B; VIETZEN, Paul S et al.Surgery. 2004, Vol 136, Num 2, pp 253-260, issn 0039-6060, 8 p.Conference Paper

The designed angiostatic peptide anginex synergistically improves chemotherapy and antiangiogenesis therapy with angiostatinDINGS, Ruud P. M; YOKOYAMA, Yumi; RAMAKRISHNAN, Sundaram et al.Cancer research (Baltimore). 2003, Vol 63, Num 2, pp 382-385, issn 0008-5472, 4 p.Article

Dual-targeting of α_vβ₃ and galectin-1 improves the specificity of paramagnetic/fluorescent liposomes to tumor endothelium in vivoKLUZA, Ewelina; JACOBS, Igor; HECTORS, Stefanie J. C. G et al.Journal of controlled release. 2012, Vol 158, Num 2, pp 207-214, issn 0168-3659, 8 p.Article

Enhancement of T-cell-Mediated Antitumor Response: Angiostatic Adjuvant to Immunotherapy against CancerDINGS, Ruud P. M; VANG, Kieng B; CASTERMANS, Karolien et al.Clinical cancer research (Print). 2011, Vol 17, Num 10, pp 3134-3145, issn 1078-0432, 12 p.Article

Identification of Novel Drug Targets for Angiostatic Cancer Therapy; It Takes Two to Tango : Angiogenesis agentsTHIJSSEN, Victor L. J. L; VAN BEIJNUM, Judy R; MAYO, Kevin H et al.Current pharmaceutical design. 2007, Vol 13, Num 35, pp 3576-3583, issn 1381-6128, 8 p.Article

Discovery of the first non-peptide antagonist of the motilin receptorBEAVERS, Mary Pat; GUNNET, Joseph W; MAYO, Kevin H et al.Drug design and discovery (Print). 2001, Vol 17, Num 3, pp 243-251, issn 1055-9612Article

Polycationic calixarene PTX013, a potent cytotoxic agent against tumors and drug resistant cancerDINGS, Ruud P. M; LEVINE, Joseph I; BROWN, Susan G et al.Investigational new drugs. 2013, Vol 31, Num 5, pp 1142-1150, issn 0167-6997, 9 p.Article

Design of nonpeptidic topomimetics of antiangiogenic proteins with antitumor activitiesDINGS, Ruud P. M; XUEMEI CHEN; HELLEBREKERS, Debby M. E. I et al.Journal of the National Cancer Institute. 2006, Vol 98, Num 13, pp 932-936, issn 0027-8874, 5 p.Article

Anti-tumor activity of the novel angiogenesis inhibitor anginexDINGS, Ruud P. M; VAN DER SCHAFT, Daisy W. J; HARGITTAI, Balazs et al.Cancer letters. 2003, Vol 194, Num 1, pp 55-66, issn 0304-3835, 12 p.Article

The antiangiogenic properties of bactericidal/ permeability-increasing protein (BPI)VAN DER SCHAFT, Daisy W. J; WAGSTAFF, John; MAYO, Kevin H et al.Annals of medicine (Helsinki). 2002, Vol 34, Num 1, pp 19-27, issn 0785-3890Article

Designed β-sheet peptides that inhibit proliferation and induce apoptosis in endothelial cellsMAYO, Kevin H; VAN DER SCHAFT, Daisy W. J; GRIFFIOEN, Arjan W et al.Angiogenesis (London). 2001, Vol 4, Num 1, pp 45-51, issn 0969-6970Article